ACA Department of Research & Development
The ACA’s researches focus on prevention and treatment of cardiovascular disease in both basic science and Chinese medicine. Its cardiovascular research center also provides advanced study environment.
Dr. Liu, as the founder of ACA, has been committed to experiment researches of HLP and AS in Columbia University College of Physicians and Surgeons, established a good, long-lasting cooperation relationship with Columbia University as well. As the 8th scientific medical college of America, Columbia University College of Physicians and Surgeons has international advanced level in prevention, treatment and scientific research of cardiovascular disease.
Prof. Li jing, as the other main person in charge, has been committed to mechanism research of cardiovascular disease, including physio-pathological changes, signaling pathway and epithelial cell regeneration. She finds a new type of calcium channel protein as a treatment target.
Dr. Quansheng Lu
Dr. Quansheng Lu is the director of Wholelife Chinese Medicine & Acupuncture Center in Rockville, MD. He acts as visiting Professor at Henan University of Chinese Medicine, China.
From 2000-2003, he was attending physician, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. From 1989 – 1997, Dr. Lu was a resident Physician in Huaiyang General Hospital, Henan, China. He holds three patents in China and has published seven professional books on TCM. He has also published 30 peer-reviewed papers in the top journals in the field, and presented his scientific findings nationally and internationally.
Dr. Jing Li
Dr. Jing Li, who was a visiting scientist of Manchester University of UK, has been committed to mechanism research of cardiovascular disease and cancer, including vascular physio-pathological changes, signaling pathway, epithelial cell regeneration and transgene as a research associate/doctor mentor/Principal Investigator of Cardiovascular Research Center, School of Medicine, University of Leeds, UK. She published over 20 international top papers, such as Nature, Nature Biotechnology, Molecular Cell, Circulation Research, ATVB and has an extraordinary achievement mainly on molecular mechanisms of vascular remodeling.
Dr. Yanzhu Liu
Dr. Yanzhu Liu is president and professer of Acupuncture Corporation of America, he earned his M.D./PhD from Beijing University of Chinese Medicine in 1996. He was an attending physician in internal medicine at First Hospital of Beijing University of Traditional Chinese Medicine. He has been active in researching atherosclerosis for 13 years, and finished his first postdoctoral training in Tshinghua University in 1998. He received a patent for his atherosclerosis treatment in China in 1998, and came to Columbia University as Associate Research Scientist in 1999 for hyperlipidemia (high fat/lipid concentration in the blood) and atherosclerosis (disease of the arteries).